Sort
261,768 grants matching “gene therapy”
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$978,042James L Riley · University Of Pennsylvania · U19 · FY2023 · AI
Elimination Racial Disparities in Hepatocellular Carcinoma
$978,037Rakesh K. Srivastava · Glax, Llc · R44 · FY2025 · MD
Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy
$977,986Hal E. Broxmeyer · Indiana University Indianapolis · U54 · FY2016 · DK
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures
$977,907Shiuan Chen · Beckman Research Institute/City Of Hope · U01 · FY2017 · ES
Iduronidase Replacement Therapy of the Brain in Hurler's Syndrome
$977,882Ruben J. Boado · Armagen Technologies, Inc. · U44 · FY2011 · NS
Genetics Of The Dominantly Inherited Periodic Fever Syndromes
$977,863Daniel L Kastner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$977,861Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
Novel Strategies to Clear Bacteria from the CF Lung
$977,764Saira Ahmad · Eldec Pharmaceuticals, Inc. · R44 · FY2023 · HL
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$977,758Jessie Villanueva · Wistar Institute · R01 · FY2025 · CA
Clinical Cancer Cytogenetics
$977,708Diane C Arthur · Basic Sciences · Z01 · FY2007 · CA
Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development
$977,652Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
$977,629David A Williams · Boston Children'S Hospital · U01 · FY2012 · AI
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
$977,604Jack A. Syage · Immunogenics, Llc · R44 · FY2020 · DK
Tulane National Primate Research Center
$977,475Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2009 · RR
MOLECULAR CLASSIFICATION OF PROSTATE CANCER
$977,375Sloan-Kettering Institute For Cancer Res · U01 · FY2003 · CA
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches
$977,362Stephen S. Rich · University Of Virginia · R01 · FY2022 · DK
Defining the genetic basis of human respiratory chain disease
$977,362Vamsi Krishna Mootha · Massachusetts General Hospital · RC2 · FY2010 · HG
Intracellular In vivo Imaging
$977,297Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
$977,273Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials
$977,234John M Olichney · University Of California At Davis · R01 · FY2017 · AG
Molecular Basis of Obesity and Obesity-induced Metabolic Diseases
$977,162Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
PRE-CLINICAL COMBINATION CHEMO- AND RADIOANTIBODY THERAP
$977,147Ctr For Molecular Medicine/Immunology · R01 · FY2004 · CA
National Ophthalmic Disease Genotyping and Phenotyping Network - eyeGENE
$977,055Santa Tumminia · National Eye Institute · ZIC · FY2013 · EY
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$977,015Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2019 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER
$976,974Dana-Farber Cancer Institute · U01 · FY2002 · CA